|
1
|
Kubiak A, Kycler W and Trojanowski M:
Epidemiology and prevention of colorectal cancer in Poland. Probl
Hig Epidemiol. 95:636–642. 2014.
|
|
2
|
Hamilton SR and Aaltonen LA: Tumours of
the colon and rectum. In: World Health Organization Classification
of TumoursPathology and Genetics of Tumours of the Digestive
System. IARC Press; Lyon: pp. 103–104. 2000
|
|
3
|
Park JH, McMillan DC, Edwards J, Horgan PG
and Roxburgh CS: Comparison of the prognostic value of measures of
the tumor inflammatory cell infiltrate and tumor-associated stroma
in patients with primary operable colorectal cancer.
Oncoimmunology. 21:e10988012016. View Article : Google Scholar
|
|
4
|
Park JH, McMillan DC, Powell AG, Richards
CH, Horgan PG, Edwards J and Roxburgh CS: Evaluation of a tumor
microenvironment-based prognostic score in primary operable
colorectal cancer. Clin Cancer Res. 21:882–888. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dvorak HF: Tumor stroma, tumor blood
vessels, and antiangiogenesis therapy. Cancer J. 21:237–243. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Conti J and Thomas G: The role of tumour
stroma in colorectal cancer invasion and metastasis. Cancers
(Basel). 3:2160–2168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Wever O, Demetter P, Mareel M and
Bracke M: Stromal myofibroblasts are drivers of invasive cancer
growth. Int J Cancer. 123:2229–2238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Crispino P, De Toma G, Ciardi A, Bella A,
Rivera M, Cavallaro G, Polistena A, Fornari F, Unim H, Pica R, et
al: Role of desmoplasia in recurrence of stage II colorectal cancer
within 5 years after surgery and therapeutic implication. Cancer
Invest. 26:419–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoong KF, Afford SC, Randhawa S, Hubscher
SG and Adams DH: Fas/Fas ligand interaction in human colorectal
hepatic metastases: A mechanism of hepatocyte destruction to
facilitate local tumor invasion. Am J Pathol. 154:693–703. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Conti JA, Kendall TJ, Bateman A, Armstrong
TA, Papa-Adams A, Xu Q, Packham G, Primrose JN, Benyon RC and
Iredale JP: The desmoplastic reaction surrounding hepatic
colorectal adenocarcinoma metastases aids tumor growth and survival
via alphav integrin ligation. Clin Cancer Res. 14:6405–6413. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui G, Goll R, Olsen T, Steigen SE,
Husebekk A, Vonen B and Florholmen J: Reduced expression of
microenvironment Th1 cytokines accompanies adenomas-carcinomas
sequence of colorectum. Cancer Immunol Immunother. 56:985–995.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mei Z, Liu Y, Liu C, Cui A, Liang Z, Wang
G, Peng H, Cui L and Li C: Tumour-infiltrating inflammation and
prognosis in colorectal cancer: Systematic review and
meta-analysis. Br J Cancer. 110:1595–1605. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group'. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, Van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. European
Organization for Research and Treatment of Cancer, National Cancer
Institute of the United States, National Cancer Institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng
P, Xu P, Zhu D, Ji M and Xu J: Tumor deposit is a poor prognostic
indicator in patients who underwent simultaneous resection for
synchronous colorectal liver metastases. Onco Targets Ther.
8:233–240. 2015.PubMed/NCBI
|
|
17
|
Morodomi T, Isomoto H, Shirouzu K,
Kakegawa K, Irie K and Morimatsu M: An index for estimating the
probability of lymph node metastasis in rectal cancers. Lymph node
metastasis and the histopathology of actively invasive regions of
cancer. Cancer. 63:539–543. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Richards CH, Flegg KM, Roxburgh CS, Going
JJ, Mohammed Z, Horgan PG and McMillan DC: The relationships
between cellular components of the peritumoural inflammatory
response, clinicopathological characteristics and survival in
patients with primary operable colorectal cancer. Br J Cancer.
106:2010–2015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Väyrynen JP, Sajanti SA, Klintrup K,
Mäkelä J, Herzig KH, Karttunen TJ, Tuomisto A and Mäkinen MJ:
Characteristics and significance of colorectal cancer associated
lymphoid reaction. Int J Cancer. 134:2126–2135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ueno H, Jones AM, Wilkinson KH, Jass JR
and Talbot IC: Histological categorisation of fibrotic cancer
stroma in advanced rectal cancer. Gut. 53:581–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klintrup K, Mäkinen JM, Kauppila S, Väre
PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ and
Mäkinen MJ: Inflammation and prognosis in colorectal cancer. Eur J
Cancer. 41:2645–2654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huijbers A, Tollenaar RA, Pelt VGW,
Zeestraten EC, Dutton S, McConkey CC, Domingo E, Smit VT, Midgley
R, Warren BF, et al: The proportion of tumor-stroma as a strong
prognosticator for stage II and III colon cancer patients:
Validation in the VICTOR trial. Ann Oncol. 24:179–185. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park JH, Richards CH, McMillan DC, Horgan
PG and Roxburgh CS: The relationship between tumour stroma
percentage, the tumour microenvironment and survival in patients
with primary operable colorectal cancer. Ann Oncol. 25:644–651.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Menon AG, Janssen-van Rhijn CM, Morreau H,
Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ and Kuppen PJ:
Immune system and prognosis in colorectal cancer: A detailed
immunohistochemical analysis. Lab Invest. 84:493–501. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Väyrynen JP, Tuomisto A, Klintrup K,
Mäkelä J, Karttunen TJ and Mäkinen MJ: Detailed analysis of
inflammatory cell infiltration in colorectal cancer. Br J Cancer.
109:1839–1847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Richards CH, Roxburgh CS, Anderson JH,
McKee RF, Foulis AK, Horgan PG and McMillan DC: Prognostic value of
tumour necrosis and host inflammatory responses in colorectal
cancer. Br J Surg. 99:287–294. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakano O, Sato M, Naito Y, Suzuki K,
Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H and Ohtani H:
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a
prognostic factor in human renal cell carcinoma: Clinicopathologic
demonstration of antitumor immunity. Cancer Res. 61:5132–5136.
2001.PubMed/NCBI
|
|
28
|
Zhang L, Conejo-Garcia JR, Katsaros D,
Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H,
Schlienger K, Liebman MN, et al: Intratumoral T cells, recurrence
and survival in epithelial ovarian cancer. N Engl J Med.
348:203–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sato E, Olson SH, Ahn J, Bundy B,
Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone
C, et al: Intraepithelial CD8+ tumor-infiltrating
lymphocytes and a high CD8+/regulatory T cell ratio are
associated with favorable prognosis in ovarian cancer. Proc Natl
Acad Sci USA. 102:18538–18543. 2005. View Article : Google Scholar : PubMed/NCBI
|
